Showing: 1 - 5 of 5 RESULTS
Industry Insights

Where to Find Cannabis Recreational Stores in Canada

As Canada became the first G7 country to legalize recreational cannabis nationwide with the Cannabis Act of 2018, there’s been a burgeoning interest in how this industry is taking shape across different provinces and territories.

Let’s dive into what the landscape looks like across Canada, keeping things simple and straightforward.


Industry Insights

The Difference Between Cannabis Cultivation Facilities and Cannabis Retail Facilities

If you’re stepping into the world of cannabis, either as a consumer or as part of the industry, it’s essential to understand the different types of facilities that play a role in getting those green goodies from seed to sale.

Two main players in this process are cultivation facilities and retail facilities. Let’s break down what each one is, what they do, and how they differ.

What is a Cannabis Cultivation Facility?…

Industry Insights

10 Things You Should Know about Cannabis Insurance as a Buyer

Entering the world of cannabis business is like stepping onto a fast-moving train. The industry’s growth is explosive, the opportunities vast, but so are the risks and regulations.

Whether you’re cultivating, manufacturing, or dispensing, one thing that should be at the top of your priority list is insurance. But not just any insurance – cannabis-specific insurance is designed to protect you from the unique risks of this industry.

In this guide, we&#…

Industry Insights

What’s Behind the Record-Breaking Cannabis Yield of All Time

The cannabis industry’s growth has been impressive, now standing as the sixth most valuable crop in the U.S.

According to Leafly’s second annual harvest report, 2022 marked a significant increase in adult-use cannabis production. A total of 2,834 metric tons were grown in 15 states where cannabis is legal for adult use, marking a 24% increase from the previous year. This substantial growth added 554 metric tons more to the production volumes.

If you’re looking to dive into the …

Industry Insights

A Look at the Cannabis Rescheduling Recommendation

Recently, there has been a significant shift in the federal government’s stance on cannabis. For over fifty years, cannabis was classified as a Schedule I drug, indicating a high potential for abuse and no accepted medical value.

However, September marked a considerable change as the Department of Health and Human Services (HHS) recommended to the Drug Enforcement Administration (DEA) that cannabis be reclassified to Schedule III.

This reclassification suggests that cannabis has a moderate to low potential for abuse, an accepted …